Lv53
1108 积分 2022-06-21 加入
Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial
8天前
已完结
Have CARs stalled for non–B-cell malignancies? Where are we, and where are we going?
16天前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
23天前
已完结
Establishment of a Rapid and Automatic Eli-TR Chimeric Antigen Receptor T Cell Manufacturing and Release Platform for the Treatment of Autoimmune Diseases, Including Membranous Nephropathy (MN)
24天前
已关闭
Study of the dynamic changes in the non-volatile chemical constituents of black tea during fermentation processing by a non-targeted metabolomics approach
1个月前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
1个月前
已完结
IL-9 signaling redirects CAR T cell fate toward CD8+ memory and CD4+ cycling states, enhancing antitumor efficacy
1个月前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
皖公网安备34019202002308
